10:00–12:00 SLEEPERS — writing
11:00–1:00 Carpet cleaning window
3:00–4:00 Dentist, crown sizing
After 4:00 Clear — gym + haircut moved to tomorrow (Wed) 5:00–7:00 PM
1. Protect the SLEEPERS block; keep the rest of recovery week light.
2. Nothing to send on END PROGRAM today — next actions land Thu Nov 5.
3. One open confirmation: the $70,000 Wealthfront outflow (Nov 2) — expected, or not?
Wendy Rohm, Sam Hiyate, and Andrea Somberg (Harvey Klinger) have the full manuscript. Yesterday's passes (Landauer, Weaver, Jacobson) were closed the same day under the successor rule — Jodi Reamer and Gaby Sheiner are in. Count corrected today at Derek's catch: the "68" in earlier briefs was the numbered send sequence, not the campaign total.
Grand Central preempted North American rights in a two-book deal. Sold by Lori Galvin at Aevitas — an agency on our watchlist. Fall 2027.
Logline: Trapped inside a self-driving car that knows her darkest secret, a grieving widow can't get out until she confesses the truth about her husband's death.
Mira acquired world English rights at auction, two books, from Kathleen Rushall at Andrea Brown.
Logline: Hell disguised as an elite law school — the professors are demons, the students are rivals, and the romance runs lovers-to-enemies.
New house Tytora bets big: a seven-book deal for the Murdle puzzle-mystery series — the week's largest commitment by volume.
Logline: Whodunit logic puzzles — from a grid of suspects and clues, deduce the killer, the weapon, and the scene of the crime.
The CNN anchor's debut graphic novel went to Top Shelf Productions, from Sloan Harris at CAA. Also this week: Duncan Fyfe's debut Henry Goodwolf at auction to Liveright; Lisina Coney's self-published Harmony Hills series in a three-book world-rights deal at Bloomsbury Archer.
Loglines — The Butcher: the decades-long hunt for Nazi war criminal Klaus Barbie. Henry Goodwolf: Benedictine monks on a medieval Scottish island come under attack by a mysterious creature. Harmony Hills: interconnected small-town romances.
The biggest book in the country overall: Jeff Kinney's Fight or Flight (Wimpy Kid — Greg Heffley's latest misadventure), per PW.
PW's Best Books of 2026 top 10 splits five novels / five nonfiction — Kevin Roose's The AGI Chronicles and Colson Whitehead's Cool Machine headline it.
Daniel H. Wilson's AI-uprising novel — long stalled as a Spielberg film — is now a TV series with Ron Howard directing the pilot and Akiva Goldsman showrunning; Amblin executive-produces. AI-catastrophe IP is finding its home in series TV.
Worldwide rights to the gothic mystery (Josh O'Connor, Patsy Ferran), theatrical run planned fall 2027 before streaming — per Deadline.
A multi-year deal for Druski's 4Lifers Entertainment to develop and produce original series, ahead of his December comedy launch (Deadline, Nov 2).
Peter Rice becomes Chief Content Officer amid a restructuring that cut roughly 1,000 jobs — a signal of how hard the streamers are re-centering on fewer, bigger bets.
Sony Music is reported nearing a ~$4 billion deal for the former Hipgnosis catalog vehicle — 45,000+ songs including Justin Bieber, Neil Young, Fleetwood Mac, and the Red Hot Chili Peppers. If it closes, it ends the Hipgnosis saga at the top of the catalog market.
US authorities approved the BMG–Concord merger with a $1.16B cash payment to Concord shareholders — creating the world's fourth-largest music company, home to Bruno Mars, Miles Davis, R.E.M., and Creedence Clearwater Revival catalogs. Close expected Q4 2026.
A catalog partnership (announced Oct 26) covering compositions and recordings across her 15 studio albums — "Family Affair," "Be Without You," "My Life." Terms undisclosed.
Reports (Oct 30) have Drake nearing a recording contract billed as the largest in industry history, after fulfilling his ~$400M UMG deal. Rumor-grade for now — watch for confirmation.
An AI system (REDMOD, reported in Gut, Mayo Clinic/BMJ) found subtle pancreatic changes on CT scans a median 475 days before diagnosis — catching 73% of future cases vs ~39% for experienced radiologists. Retrospective data; prospective trials come next.
Life Biosciences reported the first human data for ER-100, a partial-reprogramming therapy (the OSK gene trio) designed to reset age-related settings in cells without reverting them to stem cells. Evidence check: three people, open-label, company-announced — promising direction, not proof.
Vanderbilt researchers mapped 7,600+ tumors (Cell Reports Medicine, today), uncovering hidden subtypes — including a neuroendocrine form standard classification misses — and a tool to match treatment to a tumor's molecular profile rather than its label alone.
In 27,382 patients (The Lancet Digital Health), AI measurements of heart function from MRI scans were more strongly linked to survival than clinicians' own measurements — supporting AI as a first-line measuring tool, with human review.
This section joins the Brief from Wednesday Nov 4: a daily market snapshot, AI-trade sentiment, what's moving in your core holdings, and the day's key dashboard metrics — fed by a new daily input from Sage that Derek asked for today. (Sage's consolidated reports to you stay private to you, as always; this is a separate, brief-specific feed.)
The market is paying for catalogs, not content. Sony's reported ~$4B music-rights play, the $1.16B BMG–Concord merger, a seven-book bet on a puzzle series, Mary J. Blige's catalog partnership — every big check this week bought a body of work that keeps earning. That is precisely the asset you are building quietly: 335 transcripts and climbing toward 2,948 catalogued assets is not an archive project, it's catalog formation — the same asset class, in teaching form.
Your AI posture is becoming the market's position. Capability is compounding (Anthropic's ~$895B compute commitments; AI now reading pancreatic scans a year early and out-measuring cardiologists) while the rights backlash hardens (90%+ of rightsholders say generative AI hurt their earnings). Your settled stance — AI as deliberate tool, human authorship protected, "my words, my book" — sits exactly where the culture is landing. It's an ethics position that is also a brand position.
High-concept is what's selling, and that's your lane. The week's loudest fiction deal is a one-sentence premise: a widow trapped in a self-driving car that knows her secret. Meanwhile an AI-uprising novel that stalled as a film for a decade just became a Ron Howard TV series. END PROGRAM's premise travels in one sentence the same way, and its natural screen home is series — the 215 queries out are fishing in the water where buyers are demonstrably biting. The lists say the rest: Gamache #21 and Reacher #31 on top — series compound, which is what a novel-a-year builds toward.
The science is walking toward your subject. First-in-human cell reprogramming and AI diagnostics that see disease before symptoms are the early, evidence-labeled chapters of the "whole new human" story your nonfiction already tells. Worth harvesting for the show: real breakthroughs, honestly graded.
And the life underneath it: it's a recovery week, and the system ran anyway — queries closed out under the successor rule, the QC pass went to Sage, the library lanes kept transcribing, and tomorrow Sage's holdings and dashboard feed joins this page. That's plank six doing its job: the foundation carrying the vision so the man doesn't have to carry every piece of it himself.
“The impediment to action advances action. What stands in the way becomes the way.”
— Marcus Aurelius, Meditations, Book 5
Today’s reading — the passage it comes from (George Long translation): “Our actions may be impeded, but there can be no impeding our intentions or dispositions. Because we can accommodate and adapt. The mind adapts and converts to its own purposes the obstacle to our acting.”
Why this one, today: it’s recovery week — the eye is healing, the campaign sits in other people’s hands, and nothing about the mission is actually paused. The system ran, the queries are out in the world, the catalog grew. The way isn’t around this week. It’s through it.